LON:SYNC Syncona (SYNC) Share Price, News & Analysis GBX 100.52 -1.28 (-1.25%) As of 07:48 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock About Syncona Stock (LON:SYNC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Syncona alerts:Sign Up Key Stats Today's Range 100.20▼ 101.6050-Day Range 86.90▼ 101.4052-Week Range 79.60▼ 102.60Volume82,841 shsAverage Volume700,343 shsMarket Capitalization£611.37 millionP/E RatioN/ADividend Yield1.04%Price TargetGBX 189Consensus RatingBuy Company Overview Syncona's purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams. Our balance sheet underpins our strategy, enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders. Read More Syncona Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks36th Percentile Overall ScoreSYNC MarketRank™: Syncona scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingSyncona has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.Upside PotentialSyncona has a consensus price target of GBX 189, representing about 87.7% upside from its current price of GBX 100.68.Amount of Analyst CoverageSyncona has received no research coverage in the past 90 days.Read more about Syncona's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Syncona is -6.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Syncona is -6.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSyncona has a P/B Ratio of 0.57. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for SYNC. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldSyncona pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSyncona does not have a long track record of dividend growth.Read more about Syncona's dividend. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows1 people have added Syncona to their MarketBeat watchlist in the last 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Syncona insiders have not sold or bought any company stock.Percentage Held by Insiders0.75% of the stock of Syncona is held by insiders.Percentage Held by Institutions22.46% of the stock of Syncona is held by institutions.Read more about Syncona's insider trading history. Receive SYNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syncona and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SYNC Stock News HeadlinesSyncona Investment Management Limited ("SIML"): Syncona Investment Management Limited highlights progress translating frontier science into therapeutic reality at Capital ...March 19, 2026 | finanznachrichten.deSyncona Investment Management Limited highlights progress translating frontier science into therapeutic reality at Capital Markets DayMarch 19, 2026 | finance.yahoo.comThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.June 3 at 1:00 AM | American Alternative (Ad)Syncona Wins Shareholder Backing for New Investment Policy and Board RefreshMarch 3, 2026 | tipranks.comSyncona’s Quell Therapeutics Advances Lead CAR-Treg Autoimmune Therapy and Refocuses PipelineMarch 3, 2026 | tipranks.comSyncona hails biotech recovery ahead of dividend policy voteFebruary 5, 2026 | lse.co.uk2 compelling FTSE 250 stocks tipped to grow 100% (or more) in the coming yearFebruary 5, 2026 | uk.finance.yahoo.comSyncona Ups Beacon Therapeutics Stake as Gene Therapy Group Raises $75m Series CJanuary 8, 2026 | tipranks.comSee More Headlines SYNC Stock Analysis - Frequently Asked Questions How have SYNC shares performed this year? Syncona's stock was trading at GBX 95 at the start of the year. Since then, SYNC shares have increased by 6.0% and is now trading at GBX 100.68. How do I buy shares of Syncona? Shares of SYNC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Syncona own? Based on aggregate information from My MarketBeat watchlists, some other companies that Syncona investors own include Petrofac (PFC), Reckitt Benckiser Group (RKT), Barclays (BARC), B&M European Value Retail (BME), BP (BP), genedrive (GDR) and Vodafone Group Public (VOD). Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:SYNC Previous SymbolLON:BACT CIKN/A Webwww.bacitltd.com Phone17168531362FaxN/AEmployees1,208Year FoundedN/APrice Target and Rating Average Price Target for SynconaGBX 189 High Price TargetGBX 189 Low Price TargetGBX 189 Potential Upside/Downside+88.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX (15.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£16.90 million Net Margins-145.42% Pretax MarginN/A Return on Equity-9.02% Return on Assets0.40% Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.53 Sales & Book Value Annual Sales-£14.05 million Price / Sales-43.51 Cash FlowGBX 85.59 per share Price / Cash Flow1.17 Book ValueGBX 177.06 per share Price / Book0.57Miscellaneous Outstanding Shares608,193,000Free FloatN/AMarket Cap£611.37 million OptionableNot Optionable Beta0.31 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (LON:SYNC) was last updated on 6/3/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syncona Please log in to your account or sign up in order to add this asset to your watchlist. Share Syncona With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
